Cargando…
Changing the Drug Delivery System: Does it Add to Non-Compliance Ramifications Control? A Simulation Study on the Pharmacokinetics and Pharmacodynamics of Atypical Antipsychotic Drug
This study investigates the pharmacokinetic (PK) and pharmacodynamic (PD) consequences of shifting from Quetiapine fumarate immediate-release (IR) to extended-release (XR) formulation in non-adherent schizophrenia patients. Monte-Carlo simulations using population PK and PD models were implemented t...
Autor principal: | Elkomy, Mohammed H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238021/ https://www.ncbi.nlm.nih.gov/pubmed/32218187 http://dx.doi.org/10.3390/pharmaceutics12040297 |
Ejemplares similares
-
The Pharmacodynamics of Antipsychotic Drugs in Women and Men
por: Seeman, Mary V.
Publicado: (2021) -
Atypical antipsychotics as add-on treatment in late-life depression
por: Cakir, Sibel, et al.
Publicado: (2016) -
A review of pharmacokinetic and pharmacodynamic interactions with antipsychotics
por: Wijesinghe, Ruki
Publicado: (2016) -
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
por: Faries, Douglas E, et al.
Publicado: (2009) -
Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges
por: Zou, Huixi, et al.
Publicado: (2020)